[go: up one dir, main page]

ZA200803152B - Oramucosal pharmaceutical dosage form - Google Patents

Oramucosal pharmaceutical dosage form

Info

Publication number
ZA200803152B
ZA200803152B ZA200803152A ZA200803152A ZA200803152B ZA 200803152 B ZA200803152 B ZA 200803152B ZA 200803152 A ZA200803152 A ZA 200803152A ZA 200803152 A ZA200803152 A ZA 200803152A ZA 200803152 B ZA200803152 B ZA 200803152B
Authority
ZA
South Africa
Prior art keywords
oramucosal
dosage form
pharmaceutical dosage
pharmaceutical
oramucosal pharmaceutical
Prior art date
Application number
ZA200803152A
Other languages
English (en)
Inventor
Patel Rupal
Viness Pillay
Michael Paul Dankwerts
Original Assignee
Univ Witwatersrand Jhb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Witwatersrand Jhb filed Critical Univ Witwatersrand Jhb
Priority to ZA200803152A priority Critical patent/ZA200803152B/xx
Publication of ZA200803152B publication Critical patent/ZA200803152B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200803152A 2005-09-19 2008-04-10 Oramucosal pharmaceutical dosage form ZA200803152B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA200803152A ZA200803152B (en) 2005-09-19 2008-04-10 Oramucosal pharmaceutical dosage form

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200507545 2005-09-19
ZA200803152A ZA200803152B (en) 2005-09-19 2008-04-10 Oramucosal pharmaceutical dosage form

Publications (1)

Publication Number Publication Date
ZA200803152B true ZA200803152B (en) 2009-06-24

Family

ID=37889172

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200803152A ZA200803152B (en) 2005-09-19 2008-04-10 Oramucosal pharmaceutical dosage form

Country Status (5)

Country Link
US (2) US20090317470A1 (fr)
EP (1) EP1937414A4 (fr)
JP (1) JP5507840B2 (fr)
WO (1) WO2007034287A2 (fr)
ZA (1) ZA200803152B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1980240A1 (fr) * 2007-04-11 2008-10-15 Cephalon France Composition pharmaceutique lyophilisée et leurs procédés de fabrication et d'utilisation
US20090307636A1 (en) * 2008-06-05 2009-12-10 International Business Machines Corporation Solution efficiency of genetic algorithm applications
JP5580815B2 (ja) * 2008-06-19 2014-08-27 ユニバーシティ・オブ・ジ・ウィトウォーターズランド・ヨハネスブルク 経粘膜デリバリーシステム
US12186426B2 (en) * 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
CA2777218C (fr) * 2009-10-30 2016-09-27 Ix Biopharma Pte Ltd Forme posologique solide a dissolution rapide
US10413570B2 (en) * 2016-12-01 2019-09-17 Daniel McCaughan Method of manufacturing a zinc compound lozenge
CN116457022A (zh) * 2020-09-08 2023-07-18 索恩健康科技公司 可溶解基质
CN113908132A (zh) * 2021-11-09 2022-01-11 深圳市泛谷药业股份有限公司 一种阿戈美拉汀及其衍生物口腔贴片制剂及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1591624A (en) * 1977-01-24 1981-06-24 Secr Defence Acoustic wave devices
US4387355A (en) * 1980-06-13 1983-06-07 Nippon Telegraph & Telephone Public Corporation Surface acoustic wave resonator
JPS6256420A (ja) * 1985-09-05 1987-03-12 Teijin Ltd フイルム状付着性製剤
US4789549A (en) * 1987-03-09 1988-12-06 Warner-Lambert Company Sustained release dosage forms
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
US5558880A (en) * 1989-12-22 1996-09-24 Janssen Pharmaceutica Inc. Pharmaceutical and other dosage forms
JP2879695B2 (ja) * 1990-02-22 1999-04-05 日本曹達株式会社 口腔内粘膜付着性フィルム製剤
CA2128820A1 (fr) * 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Forme pharmaceutique a desintegration rapide et methode de preparation
JPH07304656A (ja) * 1993-09-10 1995-11-21 Mcneil Ppc Inc 活性成分の投与のための生物腐食性デバイス
FR2710637B1 (fr) * 1993-09-28 1995-12-08 Roquette Freres Mannitol pulvérulent de friabilité modérée et son procédé de préparation.
JPH07206710A (ja) * 1994-01-21 1995-08-08 Nitto Denko Corp 経皮投薬用テープ製剤
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
WO2001037814A1 (fr) * 1999-11-23 2001-05-31 Robert Gordon University Comprimes bicouches a administration buccale comprenant de la nicotine
FR2807034B1 (fr) * 2000-03-29 2002-06-14 Roquette Freres Mannitol pulverulent et son procede de fabrication
AU2002242138A1 (en) * 2001-02-16 2002-10-03 Lavipharm Laboratories Inc. Water soluble and palatable complexes
DE10107659B4 (de) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
DE10207394B4 (de) * 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Geschmacksmaskierte oblatenförmige Arzneizubereitung
DE10224612A1 (de) * 2002-06-04 2003-12-24 Lohmann Therapie Syst Lts Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung
DE10244504A1 (de) * 2002-09-25 2004-04-08 Capsulution Nanoscience Ag Schnellfreisetzende Darreichungsform mit schwerlöslichem Wirkstoff
WO2004096125A2 (fr) * 2003-04-14 2004-11-11 Shire Laboratories, Inc. Compositions pharmaceutiques liberant leurs principes actifs depuis un emplacement buccal ou sublingual pour resoudre un probleme de fenetre d'absorption
CA2548822C (fr) * 2003-12-08 2015-08-11 Gel-Del Technologies, Inc. Dispositifs d'administration de medicaments mucoadhesifs et procedes de fabrication et d'utilisation associes
PT1740154E (pt) * 2004-03-12 2009-09-11 Biodel Inc Composições de insulina com absorção melhorada
DK1758557T3 (da) * 2004-05-11 2011-10-24 Egalet Ltd Kvældbar doseringsform omfattende gellangummi

Also Published As

Publication number Publication date
US20090317470A1 (en) 2009-12-24
EP1937414A4 (fr) 2013-01-02
US20130252916A1 (en) 2013-09-26
WO2007034287A3 (fr) 2009-04-16
WO2007034287A2 (fr) 2007-03-29
JP2009508841A (ja) 2009-03-05
EP1937414A2 (fr) 2008-07-02
JP5507840B2 (ja) 2014-05-28

Similar Documents

Publication Publication Date Title
IL251539A0 (en) Single pharmaceutical dosage form
PL2343071T3 (pl) Farmaceutyczne postacie dawkowania
IL185390A (en) A solid dosage form
GB0501999D0 (en) Pharmaceutical compounds
GB0520657D0 (en) Pharmaceutical compounds
EP2112925A4 (fr) Formulations de dosage pharmaceutique solides
GB0520656D0 (en) Pharmaceutical compounds
IL188438A0 (en) New pharmaceutical compounds
AP2008004533A0 (en) Pharmaceutical combination
PT1957073E (pt) Medicamento
ZA200803152B (en) Oramucosal pharmaceutical dosage form
GB0513984D0 (en) Dosage form
EP1778252A4 (fr) Composes pharmaceutiques non cardiotoxiques
ZA200804666B (en) Pharmaceutical combination
GB0512643D0 (en) Pharmaceutical compounds
ZA200705612B (en) Pharmaceutical compounds
GB0501475D0 (en) Pharmaceutical compounds
GB0522989D0 (en) Dosage form
GB0507474D0 (en) Pharmaceutical compounds
GB0502055D0 (en) Pharmaceutical compounds
GB0516790D0 (en) Pharmaceutical compounds
GB0512681D0 (en) Pharmaceutical compounds
GB0512654D0 (en) Pharmaceutical compounds
GB0526607D0 (en) Pharmaceutical compounds
GB0511884D0 (en) Pharmaceutical compounds